BBNX (NASDAQ: BBNX) affiliate notifies planned sale of 16,872 shares via broker
Rhea-AI Filing Summary
Beta Bionics, Inc. affiliate files a Form 144 proposing the resale of 16,872 shares of Common Stock. The filing lists an aggregate offering value of $215,792.88 and shows shares outstanding of 44,561,695 as of 06/02/2026. The shares are described as Restricted Stock Units vesting under a registered plan with a vesting date of 06/01/2026. The broker/dealer listed is Morgan Stanley Smith Barney LLC. The filing also reports a prior sale of 3,384 shares on 03/02/2026 for $41,831.65.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies a planned affiliate resale of vested RSUs totaling 16,872 shares.
The filing identifies 16,872 shares tied to Restricted Stock Units vesting under a registered plan on 06/01/2026 and an aggregate value of $215,792.88. It lists Morgan Stanley Smith Barney LLC as the broker/dealer and reports 44,561,695 shares outstanding as of 06/02/2026. This notice is procedural under Rule 144 and signals intent to resell once conditions are met.
Execution depends on vesting and compliance with resale conditions; cash‑flow treatment is not specified in the excerpt. Subsequent SEC filings or broker disclosures will show actual transactions and timing.